Comparison of inflammatory control and safety by timing of doxycycline-azithromycin dual therapy in pediatric mycoplasmal pneumonia.

The therapeutic approach of combining doxycycline (DOX) with azithromycin (AZM) has emerged as an effective strategy for managing pediatric Mycoplasmal pneumonia (MP), with its clinical efficacy well-established. It is worth noting that both DOX and…

Preview only. Read the full abstract at the source